SS Innovations Showcases Landmark Cross-Border Robotic Telesurgery

SS Innovations International ( (SSII) ) has shared an announcement.

On May 2, 2026, SS Innovations completed a landmark long-distance cross-border telesurgery in which Dr. Mohit Bhandari performed a robotic gastrojejunostomy on a patient in Indore, India, while operating from the Royal Australian College of Surgeons in Perth, Australia, more than 4,500 miles away. The procedure used the portable SSi MantrAsana tele-surgeon console linked to the SSi Mantra robotic system, underscoring the platform’s ultra-low latency, high-definition visualization and precise control, and highlighting SS Innovations’ growing track record of more than 170 telesurgeries as it positions itself as a pioneer in remote robotic surgery and expanded access to specialist care.

The demonstration at a major surgical congress reinforces SS Innovations’ bid to differentiate itself in the competitive surgical robotics market through cost-effective, highly portable telesurgery capabilities. By enabling complex operations to be conducted safely across international borders, the company is signaling potential shifts in how surgical expertise can be deployed globally, with implications for hospitals, surgeons and patients in underserved regions.

Spark’s Take on SSII Stock

According to Spark, TipRanks’ AI Analyst, SSII is a Neutral.

The score is driven primarily by weak financial quality (ongoing losses and worsening cash burn) and bearish technicals (below key moving averages with negative MACD). Offsetting factors include strong revenue growth, an improved balance sheet, and positive corporate momentum from adoption milestones, regulatory wins, and new capital raised.

To see Spark’s full report on SSII stock, click here.

More about SS Innovations International

SS Innovations International, Inc. is a Nasdaq-listed medical technology company developing surgical robotic systems aimed at making robotic surgery more affordable and accessible globally. Headquartered in India, the American company’s portfolio centers on its SSi Mantra robotic platform and SSi Mudra surgical instruments, which support a wide range of procedures, including complex cardiac operations.

Average Trading Volume: 70,009

Technical Sentiment Signal: Sell

Current Market Cap: $814.9M

For detailed information about SSII stock, go to TipRanks’ Stock Analysis page.